Intraperitoneal administration of CDP-choline or a combination of cytidine plus choline improves nerve regeneration and functional recovery in a rat model of sciatic nerve injury

Neurological Research

Volumn 34, Issue 3, 2012, Pages 238-245

  Caner, Basak ^a   Ilker Kafa, M ^b   Bekar, Ahmet ^b   Ayberk Kurt, M ^b   Karli, Necdet ^b   Cansev, Mehmet ^b   Ulus, Ismail H ^c  

^a MINISTRY OF HEALTH   (Turkey)

^b ULUDAG UNIVERSITY   (Turkey)

^c ACIBADEM UNIVERSITY   (Turkey)

Author keywords

Choline; Citicoline; Cytidine; Nerve regeneration; Sciatic nerve

Indexed keywords

CHOLINE; CITICOLINE; CYTIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOTOMY; CONTROLLED STUDY; DRUG EFFECT; ELECTROMYOGRAPHY; FEMALE; MUSCLE ACTION POTENTIAL; NERVE FIBER; NERVE REGENERATION; NONHUMAN; PERIPHERAL NERVE INJURY; RAT; SCIATIC NERVE;

ANIMALS; AXOTOMY; CHOLINE; CYTIDINE; CYTIDINE DIPHOSPHATE CHOLINE; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; FEMALE; INJECTIONS, INTRAPERITONEAL; NERVE REGENERATION; NOOTROPIC AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SCIATIC NERVE; SCIATIC NEUROPATHY;

EID: 84859308948     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132812Y.0000000003     Document Type: Article

References (44)

1. Kennedy EM, Weiss SB. The function of cytidine coenzymes in the biosynthesis of phospholipids. J Biol Chem. 1956;222: 193-214.
2. Weiss GB. Metabolism and actions of CDP-Choline as an endogenous compound and administered exogenously as citicoline. Life Sci. 1995;56:637-60.
3. Adibhatla RM, Hatcher JF, Dempsey RJ. Citicoline: neuroprotective mechanisms in cerebral ischemia. J Neurochem. 2002;80:12-23.
4. Adibhatla RM, Hatcher JF. Cytidine 59-diphosphocholine (CDP-Choline) in stroke and other CNS disorders. Neurochem Res. 2005;30:15-23.
5. Saver JL. Citicoline: update on a promising and widely available agent for neuroprotection and neurorepair. Rev Neurol Dis. 2008;5:167-77.
6. Secades JJ, Lorenzo JL. Citicoline: pharmacological and clinical review, 2006 update. Methods Find Exp Clin Pharmacol. 2006;28(Suppl B):1-56.
7. Rao AM, Hatcher JF, Dempsey RJ. Lipid alterations in transient forebrain ischemia: possible new mechanisms of CDPcholine neuroprotection. J Neurochem. 2000;75:2528-35.
8. Adibhatla RM, Hatcher JF, Dempsey RJ. Effects of citicoline on phospholipid and glutathione levels in transient cerebral ischemia. Stroke. 2001;32:2376-81.
9. Adibhatla RM, Hatcher JF. Citicoline decreases phospholipase A2 stimulation and hydroxyl radical generation in transient cerebral ischemia. J Neurosci Res. 2003;73:308-15.
10. Adibhatla RM, Hatcher JF, Larsen EC, Chen X, Sun D, Tsao FH. CDP-choline significantly restores phosphatidylcholine levels by differentially affecting phospholipase A2 and CTP: phosphocholine ctydiyltransferase after stroke. J Biol Chem. 2006;281:6718-25.
11. Aronowski J, Strong R, Grotta JC. Citicoline for treatment of experimental focal ischemia: histological and behavioral outcome. Neurol Res. 1996;18:570-4.
12. Onal MZ, Li F, Tatlisumak T, Locke KW, Sandage BW Jr, Fisher M. Synergistic effects of citicoline and MK-801 in temporary experimental focal ischemia in rats. Stroke. 1997;28:1060-5.
13. Schabitz WR, Li F, Irie K, Sandage BW, Locke KW, Fisher M. Synergistic effects of a combination of low-dose basic fibroblast growth factor and citicoline after temporary experimental focal ischemia. Stroke. 1999;30:427-32.
14. Sobrado M, Lopez MG, Carceller F, Garcia AG, Roda JM. Combined nimodipine and citicoline reduce infarct size, attenuate apoptosis and increase BCL-2 expression after focal cerebral ischemia. Neuroscience. 2003;118:107-13.
15. Andersen M, Overgaard K, Meden P, Boysen G. Effects of citicoline combined with thrombolytic therapy in a rat embolic stroke model. Stroke. 1999;30:1464-74.
16. Hurtado O, Cardenas A, Sanchez V, Pradillo JM, Morales JR, Ortego F, et al. A chronic treatment with CDP-choline improves functional recovery and increases neuronal plasticity after experimental stroke. Neurobiol Dis. 2007;26:105-11.
17. Fresta M, Puglisi G. Survival rate improvement in a rat ischemia model by long circulating liposomes containing cytidine-59-diphosphate choline. Life Sci. 1997;61:1227-35.
18. Alkan T, Kahveci N, Gö ren B, Korfali E, Ozluk K. Ischemic brain injury caused by interrupted versus uninterrupted occlusion in hypotensive rats with subarachnoid hemorrhage: neuroprotective effects of citicoline. Arch Physiol Biochem. 2001;109:161-7.
19. Baskaya MK, Dogan A, Rao M, Dempsey RJ. Neuroprotective effects of citicoline on brain edema and blood-brain breakdown after traumatic brain injury. J Neurosurg. 2000;92: 448-52.
20. Dixon CE, Ma XC, Marion DW. Effects of CDP-choline treatment on neurobehavioral deficits after TBI and on hippocampal and neocortical acetylcholine release. J Neurotrauma. 1997;14:161-9.
21. Turkkan A, Alkan T, Goren B, Kocaeli H, Akar E, Korfali E. Citicoline and postconditioning provides neuroprotection in a rat model of ischemic spinal cord injury. Acta Neurochir (Wien). 2010;152:1033-42.
22. Yucel N, Cayli SR, Ate O, Karadag N, Firat S, Turkoz Y. Evaluation of the neuroprotective effects of citicoline after experimental spinal cord injury: improved behavioral and neuroanatomical recovery. Neurochem Res. 2006;31: 767-75.
23. Clark WM, Warach SJ, Pettigrew LC, Gammans RE, Sabounjian LA. A randomized dose-response trial of citicoline in acute ischemic stroke patients. Neurology. 1997;49:671-8.
24. Clark WM, Williams BJ, Selzer KA, Zweifler RM, Sabounjian LA, Gammanas RE. A randomized efficacy trial of citicoline in patients with acute ischemic stroke. Stroke. 1999;30:2592-7.
25. Tazaki Y, Sakai F, Otomo E, Kutsuzawa T, Kameyama M, Omae T, et al. Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebocontrolled study. Stroke. 1988;19:211-6.
26. Warach S, Pettigrew LC, Dashe JF, Pullicino P, Lefkowitz DM, Sabounjian LA, et al. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators. Ann Neurol. 2000;48:713-22.
27. Ozay R, Bekar A, Kocaeli H, Karli N, Filiz G, Ulus IH. Citicoline improves functional recovery, promotes nerve regeneration, and reduces postoperative scarring after peripheral nerve surgery in rats. Surg Neurol. 2007;68:615-22.
28. Aslan E, Kocaeli H, Bekar A, Tolunay S, Ulus IH. CDPcholine and its endogenous metabolites, cytidine and choline, promote the nerve regeneration and improve the functional recovery of injured rat sciatic nerves. Neurol Res. 2011;33:766-73.
29. Wurtman RJ, Reagan M, Ulus IH, Yu L. Effect of oral CDPcholine on plasma choline and uridine levels in humans. Biochem Pharmacol. 2000;60:989-92.
30. Wurtman RJ, Ulus IH, Cansev M, Watkins CJ, Wang L, Marzloff G. Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally. Brain Res. 2006;1088:83-92.
31. Richardson UI, Watkins CJ, Pierre C, Ulus IH, Wurtman RJ. Stimulation of CDP-choline synthesis by uridine or cytidine in PC12 rat pheochromacytoma cells. Brain Res. 2003;971:161-7.
32. Ulus IH, Watkins CJ, Cansev M, Wurtman RJ. Cytidine and uridine increase striatal CDP-choline levels without decreasing acetylcholine synthesis and release. Cell Mol Neurobiol. 2006;26:563-77.
33. Cansev M, Watkins CJ, van der Beek EM, Wurtman RJ. Oral uridine-59-monophosphate (UMP) increases brain CDP-choline levels in gerbils. Brain Res. 2005;1058:101-8.
34. Cansev M, Wurtman RJ, Sakamoto T, Ulus IH. Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses. Alzheimers Dement. 2008;4(1 Suppl 1):S153-8.
35. Ilcol YO, Cansev M, Yilmaz MS, Hamurtekin E, Ulus IH. Intraperitoneal administration of CDP-choline and its cholinergic and pyrimidinergic metabolites induce hyperglycemia in rats: involvement of the sympathoadrenal system. Arch Physiol Biochem. 2007;113:186-201.
36. Cansev M, Ilcol YO, Yi{dotless}lmaz MS, Hamurtekin E, Ulus IH. Peripheral administration of CDP-choline, phosphocholine or choline increases plasma adrenaline and noradrenaline concentrations. Autonom Autocoid Pharmacol. 2008;28: 41-58.
37. Cansev M, Yilmaz MS, Ilcol YO, Hamurtekin E, Ulus IH. Cardiovasvular effects of CDP-choline and its metabolites: involvement of peripheral autonomic nervous system. Eur J Pharmacol. 2007;577:129-42.
38. Hare GM, Evans PJ, Mackinnon SE, Best TJ, Bain JR, Szalai JP, et al. Walking track analysis: a long-term assessment of peripheral nerve recovery. Plast Reconstr Surg. 1992;89: 251-8.
39. Kanaya F, Firrell JC, Breidenbach WC. Sciatic function index, nerve conduction tests, muscle contraction, and axon morphometry as indicators of regeneration. Plast Reconstr Surg. 1996;98:1264-74.
40. Petersen J, Russell L, Andrus K, MacKinnon M, Silver J, Kilot M. Reduction of extraneural scarring by ADCON-T/N after surgical intervention. Neurosurgery. 1996;38:976-83.
41. Larsen JO. Stereology of nerve cross sections. J Neurosci Methods. 1998;85:107-18.
42. Kaplan S, Geuna S, Ronchi G, Ulkay MB, von bartheld CS. Calibration of the stereological estimation of the number of myelinated axons in the rat sciatic nerve: a multicenter study. J Neurosci Methods. 2010;187:90-9.
43. de Lecinana MA, Gutierrez M, Roda JM, Carceller F, Diez-Tejedor E. Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke. J Neurol Sci. 2006;247:121-9.
44. Menku A, Ogden M, Saraymen R. The protective effects of propofol and citicoline combination in experimental head injury in rats. Turk Neurosurg. 2010;20:57-62.